Group 1 - As of October 31, 2025, Jiangsu has a total of 715 listed companies, including 220 on the Shanghai Stock Exchange Main Board, 114 on the Sci-Tech Innovation Board, 125 on the Shenzhen Stock Exchange Main Board (including one pure B-share), 203 on the Growth Enterprise Market, and 53 on the Beijing Stock Exchange [1] - In October 2025, Jiangsu added one new listed company (Changjiang Nengke), bringing the total number of new listings in 2025 to 21 [1] - The total market capitalization of the 714 listed companies in Jiangsu is 85,985.35 billion yuan, accounting for 13.12% of the total number of A-share listed companies and 8.01% of their total market capitalization [3] Group 2 - As of October 31, 2025, the companies in Jiangsu with a market capitalization exceeding 100 billion yuan (excluding the Beijing Stock Exchange) include Hengrui Medicine, WuXi AppTec, Jiangsu Bank, Guodian Nari, Huatai Securities, Nanjing Bank, Huidian Co., S. Hengli Hydraulic, Dongshan Precision, Xugong Machinery, Tianfu Communication, and Yanghe Brewery [5] - The bottom ten ranked A-share listed companies in Jiangsu (excluding the Beijing Stock Exchange) are Yangzi New Materials, Nanwei Co., Guangge Technology, Xuelang Environment, Zhongshe Co., *ST Hengjiu, Ailong Technology, Jinpu Garden, *ST Tianlong, and *ST Suwu [7] - In October 2025, Jiangsu's A-share listed companies had a total of 3 financing events, raising a total of 1.269 billion yuan, while the total financing events for the year reached 49, raising a total of 61.438 billion yuan [7]

南卫股份11月5日公告称，江苏证监局对公司控股股东及实际控制人李平、公司前任财务总监项琴华内 幕交易"南卫股份"违法行为进行了立案调查，下发《行政处罚决定书》。 《行政处罚决定书》显示，2023年1月底，年审会计师发现公司有倒贷的资金被挪用尚未归还的情况， 后明确内部控制审计报告会出具否定意见。 李平、项琴华作为内幕信息知情人，集中卖出公司股票避损。江苏证监局对李平没收违法所得1177.67 万元，并处以罚款3533万元；对项琴华没收违法所得10.17万元，并处以罚款150万元。 值得关注的是，这起内幕交易案背后，审计机构坚守职业底线，面对上市公司试图修改审计结论的要 求，明确拒绝"妥协"，成为审计机构坚守独立性的正面范本。 《行政处罚决定书》显示，公司前任董事会秘书李某向天衡所负责人郭某咨询审计报告的结论能否修 改，郭某明确告诉李某，结论是确定的，不可能修改。 明确内部控制审计报告 会出具否定意见 2023年3月2日，罗某华、孙某薇二人结合类似情况，确定拟对公司2022年度财务报告出具非标准意见的 审计报告，拟对2022年度内部控制情况出具否定意见审计报告。当天15时12分，罗某华联系李某，欲通 过李某约公 ...

Core Viewpoint - The case of insider trading involving Nanwei Co., Ltd. has resulted in significant penalties for its controlling shareholder and former CFO, totaling 36.83 million yuan, highlighting the consequences of using insider information to avoid potential losses [1][4][9]. Group 1: Insider Trading Case - The Jiangsu Securities Regulatory Commission issued administrative penalties against Li Ping and Xiang Qinhua for insider trading, with Li Ping being fined 35.33 million yuan and Xiang Qinhua 1.5 million yuan [1][4]. - Li Ping and Xiang Qinhua utilized insider information to sell shares of Nanwei Co., Ltd. to avoid losses, with Li Ping selling 8.184 million shares for 47.97 million yuan, avoiding losses of 11.77 million yuan, and Xiang Qinhua selling 54,000 shares for 340,500 yuan, avoiding losses of 101,700 yuan [9]. Group 2: Company Background and Financial Performance - Nanwei Co., Ltd. specializes in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, first aid kits, and sports protection products, and has been publicly listed since 2017 [10]. - The company has faced significant challenges, including continuous losses for four consecutive years, with net profits of -22.76 million yuan, -14.65 million yuan, -147 million yuan, and -191 million yuan from 2021 to 2024 [10]. - In the first three quarters of 2025, the company reported revenue of 447 million yuan, a year-on-year decrease of 1.7%, and a net profit loss of 24.93 million yuan, a decrease of 87.25% year-on-year, attributed to intense market competition and rising costs [11].

Core Viewpoint - Jiangsu Nanfang Weicai Pharmaceutical Co., Ltd. (referred to as "Nanfang Weicai") is facing significant challenges, including penalties for insider trading against its controlling shareholder and former CFO, high share pledges, and continuous financial losses [1][2][5]. Insider Trading and Regulatory Actions - The actual controller Li Ping and former CFO Xiang Qinhua were penalized by the Jiangsu Regulatory Bureau of the China Securities Regulatory Commission for insider trading, with Li Ping fined a total of 470 million yuan [2][4]. - Li Ping sold 8.184 million shares of Nanfang Weicai for approximately 47.97 million yuan during the sensitive period, avoiding losses of about 11.78 million yuan [3]. - Xiang Qinhua sold 54,000 shares for 340,500 yuan, avoiding losses of 101,700 yuan [4]. Financial Performance and Losses - Nanfang Weicai has reported continuous losses for four consecutive years, with total losses exceeding 400 million yuan [8]. - Revenue figures from 2021 to 2025 show slight growth, with revenues of 527 million yuan, 545 million yuan, 600 million yuan, 603 million yuan, and 447 million yuan respectively, while net profits have been negative [8]. Share Pledge Situation - Li Ping has pledged a significant portion of his shares, with 73.54% of his holdings pledged, amounting to 30.24% of the total shares [7]. - The upcoming share pledges due in the next six months amount to 59.4 million shares, representing 20.55% of the total shares [7]. Debt and Financial Health - The company's debt-to-asset ratio has been increasing, reaching 73.08% in 2024 and 73.87% by September 2025 [8]. - As of September 2025, total assets were reported at 993 million yuan, with total liabilities at 734 million yuan [8].

Core Viewpoint - The actual controller of Nanwei Co., Ltd. (603880.SH), Li Ping, sold shares worth 47.96 million yuan to avoid losses exceeding 11 million yuan after learning about a negative internal control report from the accounting firm, leading to severe penalties from the China Securities Regulatory Commission (CSRC) for insider trading [1][2][3]. Group 1: Insider Trading Incident - Li Ping and former financial director Xiang Qinhua received administrative penalties from the Jiangsu Regulatory Bureau of the CSRC for insider trading, with Li Ping facing a total penalty of over 47.1 million yuan and Xiang Qinhua approximately 1.6 million yuan [1][2]. - The insider trading occurred during a sensitive period from March 1 to April 28, 2023, when the company was aware of significant issues regarding fund occupation [2][3]. - Li Ping sold 8.184 million shares between March 14 and 28, 2023, while Xiang Qinhua sold 54,000 shares on March 21 and 22, both actions deemed violations of the Securities Law [2][3]. Group 2: Company Performance and Financials - Nanwei Co., Ltd. has faced increasing losses since 2022, with revenues of 5.45 billion yuan in 2022, 6 billion yuan in 2023, and projected 6.03 billion yuan in 2024, while net profits were -14.65 million yuan, -147 million yuan, and -191 million yuan respectively [4]. - The company attributed the projected losses in 2024 to intense competition in the nitrile glove industry, declining product prices, and rising raw material costs, particularly for nitrile latex [4].

Core Viewpoint - The administrative penalties for insider trading involving the actual controller and former financial director of Nanwei Co., Ltd. have been officially issued, highlighting regulatory actions against insider trading practices in the company [1] Summary by Relevant Sections - **Insider Trading Case** - The actual controller and major shareholder of Nanwei Co., Ltd., Li Ping, and former financial director, Xiang Qinhua, received administrative penalties from the Jiangsu Securities Regulatory Bureau for insider trading [1] - **Financial Penalties** - Li Ping avoided losses of approximately 11.77 million yuan through insider trading, resulting in the confiscation of illegal gains of about 11.77 million yuan and a fine of approximately 35.33 million yuan [1] - Xiang Qinhua avoided losses of about 101,700 yuan, leading to the confiscation of illegal gains of 101,700 yuan and a fine of 1.5 million yuan [1] - The total penalties imposed on both individuals amount to approximately 48.71 million yuan [1] - **Regulatory Timeline** - Both Li Ping and Xiang Qinhua received a notice of investigation from the Securities Regulatory Commission on October 23, 2024, due to suspected insider trading [1] - On August 7, 2025, they received a prior notice of administrative punishment from the Jiangsu Securities Regulatory Bureau [1]

Core Viewpoint - The company, Jiangsu Nanwei Medical Co., Ltd., is facing regulatory scrutiny due to insider trading activities involving its actual controller and former financial director, which has led to significant financial penalties but is stated not to affect the company's operations or listing status [2][4]. Group 1: Regulatory Actions - Li Ping, the actual controller and chairman, sold 8.184 million shares of Nanwei Co. during the sensitive period, resulting in a transaction amount of 47.9678 million yuan and an avoidance of losses amounting to 11.7767 million yuan [2]. - Xiang Qinhua, the former financial director, sold 54,000 shares during the same period, with a transaction amount of 340,500 yuan and an avoidance of losses of 101,700 yuan [2]. - The Jiangsu Regulatory Bureau decided to confiscate illegal gains of 11.7767 million yuan from Li Ping and impose a fine of 35.33 million yuan, while Xiang Qinhua will have 101,700 yuan confiscated and face a fine of 1.5 million yuan [2]. Group 2: Company Performance - Nanwei Co. reported a revenue of approximately 447 million yuan for the first three quarters of 2025, reflecting a year-on-year decrease of 1.7% [3]. - The net loss attributable to shareholders for the same period was approximately 24.93 million yuan, with a basic earnings per share loss of 0.086 yuan [3]. - As of November 4, the company's stock price was 6.84 yuan, with a total market capitalization of 2 billion yuan [3]. Group 3: Company Overview - Nanwei Co. specializes in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, sports protection products, first aid kits, and nursing products [3]. - The company has established a strong partnership with Yunnan Baiyao Group, becoming the exclusive supplier of certain products [3].

Core Points - The chairman and former financial director of Nanwei Co., Ltd. were penalized for insider trading, with total fines and confiscated profits exceeding 48.7 million yuan [2][3]. Group 1: Insider Trading Penalties - Li Ping, the actual controller and chairman, sold 8.184 million shares of Nanwei Co., Ltd. during the sensitive period, with a transaction amount of 47.9678 million yuan, avoiding losses of 11.7767 million yuan [5]. - Xiang Qinhua, the former financial director, sold 54,000 shares during the same period, with a transaction amount of 340,500 yuan, avoiding losses of 101,700 yuan [5]. - The Jiangsu Regulatory Bureau decided to confiscate Li Ping's illegal gains of 11.7767 million yuan and impose a fine of 35.33 million yuan, while Xiang Qinhua faced confiscation of 101,700 yuan and a fine of 1.5 million yuan [5]. Group 2: Company Operations and Financial Performance - Nanwei Co., Ltd. primarily engages in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, sports protection products, first aid kits, and nursing products [6]. - As of the end of Q3 2025, the company reported revenue of approximately 447 million yuan, a year-on-year decrease of 1.7%, and a net loss attributable to shareholders of 24.93 million yuan, further widening the loss [8]. - Li Ping, aged 65, is the largest shareholder of Nanwei Co., Ltd., holding 119 million shares, accounting for 41.12% of the total shares [6][7].

《南卫股份关于公司相关人员收到中国证券监督管理委员会《行政处罚决定书》的公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年11月4日收盘，南卫股份（603880）报收于6.84元，较前一交易日上涨0.44%，最新总市值为 19.77亿元。该股当日开盘6.83元，最高6.88元，最低6.77元，成交额达4598.71万元，换手率为2.33%。 近日，南卫股份发布公告称，公司控股股东及实际控制人李平、前任财务总监项琴华因涉嫌内幕交易， 分别于2025年11月4日收到中国证监会江苏监管局下发的《行政处罚决定书》。经查，2023年3月1日公 司资金占用问题基本确认，构成内幕信息，敏感期为2023年3月1日至4月28日。李平在敏感期内控制账 户卖出"南卫股份"818.40万股，避损11,776,667.59元；项琴华在敏感期内卖出5.4万股，避损101,675.47 元。二人行为构成内幕交易，证监会决定对李平没收违法所得并罚款35,330,002.77元，对项琴华没收违 法所得并罚款1,500,000.00元。上述处罚不涉 ...

Core Viewpoint - The chairman and former financial director of Nanwei Co., Ltd. have been penalized for insider trading, with total fines and confiscated profits exceeding 48.7 million yuan [2][4]. Group 1: Insider Trading Penalties - On November 4, Nanwei Co., Ltd. announced that its actual controller and chairman, Li Ping, along with former financial director, Xiang Qinhua, received an administrative penalty from the Jiangsu Regulatory Bureau of the China Securities Regulatory Commission for insider trading [4]. - Li Ping sold 8.184 million shares of Nanwei Co., Ltd. during the sensitive period of insider information, with a transaction amount of 47.9678 million yuan, avoiding losses of 11.7767 million yuan [6]. - Xiang Qinhua sold 54,000 shares during the same period, with a transaction amount of 340,500 yuan, avoiding losses of 101,700 yuan [6]. - The penalties include confiscation of illegal gains and fines: Li Ping was fined 35.33 million yuan and had 11.7767 million yuan confiscated, while Xiang Qinhua was fined 1.5 million yuan and had 101,700 yuan confiscated [7]. Group 2: Company Performance and Operations - Nanwei Co., Ltd. primarily engages in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, sports protection products, first aid kits, and nursing products [9]. - As of the end of Q3 2025, the company reported revenue of approximately 447 million yuan, a year-on-year decrease of 1.7%, and a net loss attributable to shareholders of 24.93 million yuan, indicating an expanded loss [10]. - The company stated that the administrative penalties do not involve the company itself and will not affect its daily operations, which are currently normal [7].